Propofol and Fentanyl Pharmacokinetics and Pharmacodynamics in Extracorporeal Membrane Oxygenation

<b>Rationale:</b> Despite the potential risks associated with sedation, there is a paucity of pharmacokinetic/pharmacodynamic (PK/PD) data for propofol and fentanyl in patients supported with venovenous extracorporeal membrane oxygenation (V-V ECMO). <b>Objective:</b> Describe propofol and fentanyl PK/PD profiles in patients receiving V-V ECMO. <b>Methods:</b> Prospective, single-center, open-label PK/PD study at the Toronto General Hospital intensive care unit between July 2022 and January 2023. Using high-performance liquid chromatography/tandem mass spectrometry, propofol and fentanyl total concentrations were measured during V-V ECMO. Sequential PK/PD modeling, using sex as a covariate, was conducted with processed electroencephalography (patient state index [PSI]) for sedation and expiratory occlusion pressure and airway occlusion pressure during the first 0.1 second for respiratory effort. <b>Results:</b> Eleven patients underwent 106 evaluations over a median follow-up of 146 (interquartile ranges, 116-146) hours. Patients' average age was 43 (standard deviation, 13) years, and 55% were female. Propofol and fentanyl PKs were best described by a two-compartment model. Propofol PSI PD were described using an effect compartment, with a coefficient of determination of 0.78. There was a significant increase in propofol (<i>P</i> = 0.01) and fentanyl (<i>P</i> = 0.03) clearance within 10 minutes of ECMO initiation, plateauing after 8 hours of ECMO support. Despite this, patient oversedation (PSI <40) occurred in 74% of the observations. Female patients exhibited a higher sedative central volume of distribution and lower propofol clearance. <b>Conclusions:</b> ECMO initiation resulted in a time-limited increased sedative clearance. PSI accurately described sedative PD, but variable respiratory effort was observed irrespective of sedative plasma concentrations. Sex-based differences were found in sedative PK/PD parameters.

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2024-10-09
DOI
https://doi.org/10.1513/annalsats.202407-795oc
Citations
5
Primary Topic
Antibiotics Pharmacokinetics and Efficacy
Type
article
Field-Weighted Citation Impact
2.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Propofol and Fentanyl Pharmacokinetics and Pharmacodynamics in Extracorporeal Membrane Oxygenation

María Patricia Hernández-Mitre, Diana Morales Castro, Kiran Shekar, Jack Uetrecht et al.
5 citations
Annals of the American Thoracic Society
Antibiotics Pharmacokinetics and Efficacy
2.24
article

Propofol and Fentanyl Pharmacokinetics and Pharmacodynamics in Extracorporeal Membrane Oxygenation

María Patricia Hernández-Mitre, Diana Morales Castro, Kiran Shekar, Jack Uetrecht, John Thomas Granton, Mohd H. Abdul‐Aziz, Manuel Tisminetzky, Idunn S. Morris, Linda Dresser, Eric X. Chen, Eleonora Balzani, Irene Wong, J. Turgeon, K. Sandy Pang, Eddy Fan, Felipe Jurado-Camacho
article en
5 citations

Abstract

<b>Rationale:</b> Despite the potential risks associated with sedation, there is a paucity of pharmacokinetic/pharmacodynamic (PK/PD) data for propofol and fentanyl in patients supported with venovenous extracorporeal membrane oxygenation (V-V ECMO). <b>Objective:</b> Describe propofol and fentanyl PK/PD profiles in patients receiving V-V ECMO. <b>Methods:</b> Prospective, single-center, open-label PK/PD study at the Toronto General Hospital intensive care unit between July 2022 and January 2023. Using high-performance liquid chromatography/tandem mass spectrometry, propofol and fentanyl total concentrations were measured during V-V ECMO. Sequential PK/PD modeling, using sex as a covariate, was conducted with processed electroencephalography (patient state index [PSI]) for sedation and expiratory occlusion pressure and airway occlusion pressure during the first 0.1 second for respiratory effort. <b>Results:</b> Eleven patients underwent 106 evaluations over a median follow-up of 146 (interquartile ranges, 116-146) hours. Patients' average age was 43 (standard deviation, 13) years, and 55% were female. Propofol and fentanyl PKs were best described by a two-compartment model. Propofol PSI PD were described using an effect compartment, with a coefficient of determination of 0.78. There was a significant increase in propofol (<i>P</i> = 0.01) and fentanyl (<i>P</i> = 0.03) clearance within 10 minutes of ECMO initiation, plateauing after 8 hours of ECMO support. Despite this, patient oversedation (PSI <40) occurred in 74% of the observations. Female patients exhibited a higher sedative central volume of distribution and lower propofol clearance. <b>Conclusions:</b> ECMO initiation resulted in a time-limited increased sedative clearance. PSI accurately described sedative PD, but variable respiratory effort was observed irrespective of sedative plasma concentrations. Sex-based differences were found in sedative PK/PD parameters.

Annals of the American Thoracic SocietyVol. 22(1)
3M (United States) (US), The University of Queensland (AU), University of Toronto (CA), Nepean Hospital (AU), Toronto General Hospital (CA), Prince Charles Hospital (AU)
Openalex Percentile: Top 12%
Antibiotics Pharmacokinetics and Efficacy
2.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.